Shailesh Maingi, Inceptor founder and CEO
Not one, not two, but three — biotech claims it will pursue CARs T, M and NK all at once
An oncology startup is touting some really, really bold claims.
Inceptor Bio announced its latest round of funding Thursday at $37 million, which it plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.